SOUTH SAN FRANCISCO, Calif.,
Feb. 24, 2020 /PRNewswire/
-- Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA)
today announced that the Company will participate in the following
conferences in March.
- Cowen 40th Annual Health Care Conference on
Tuesday, March 3, 2020, at
10:00 a.m. ET in Boston, MA.
- Oppenheimer 30th Annual Healthcare Conference on
Tuesday, March 17, 2020, at
2:45 p.m. ET in New York, NY.
Both presentations will be webcast live and available for replay
in the Investor Relations section of the Portola website at
http://investors.portola.com.
About Portola Pharmaceuticals, Inc.
Portola
Pharmaceuticals is a global, commercial-stage biopharmaceutical
company focused on the discovery, development and commercialization
of novel therapeutics that could significantly advance the fields
of thrombosis and other hematologic conditions. The Company's first
two commercialized products are Andexxa® [coagulation
factor Xa (recombinant), inactivated-zhzo], marketed in
Europe as Ondexxya®
(andexanet alfa), and Bevyxxa® (betrixaban). The company
also is advancing cerdulatinib, a SYK/JAK inhibitor being developed
for the treatment of hematologic cancers. Founded in 2003 in
South San Francisco, California,
Portola has operations in
the United States and Europe.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/portola-pharmaceuticals-to-participate-in-two-upcoming-investor-conferences-301008682.html
SOURCE Portola Pharmaceuticals, Inc.®